UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029968
Receipt number R000033917
Scientific Title Clinical research on the effect of induing the secretion of s-IgA in saliva on Leuconostoc mesenteroides NTM048 strain
Date of disclosure of the study information 2017/11/15
Last modified on 2020/02/06 14:51:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical research on the effect of induing the secretion of s-IgA in saliva on Leuconostoc mesenteroides NTM048 strain

Acronym

Clinical research on the effect of induing the secretion of s-IgA in saliva on Leuconostoc mesenteroides NTM048 strain

Scientific Title

Clinical research on the effect of induing the secretion of s-IgA in saliva on Leuconostoc mesenteroides NTM048 strain

Scientific Title:Acronym

Clinical research on the effect of induing the secretion of s-IgA in saliva on Leuconostoc mesenteroides NTM048 strain

Region

Japan


Condition

Condition

Cedar pollinosis

Classification by specialty

Oto-rhino-laryngology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigate the secretion promoting effect of s-IgA in saliva by lactic acid bacteria

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Change of s-IgA secreation

Key secondary outcomes

(1)Time course of s-IgA in saliva
(2)Number of infections of influenza and viral emesis diarrhea
(3)POMS 2 (mood profile test)
(4)Stool frequency
(5)Characteristics of stool
(6)Organic acid in stool
(7)Bacterial flora in stools
The evaluation items below are done in the cedar pollinosis group
(8)Specific IgE (cedar) concentration in blood
(9)Nasal symptom score


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Take two capsules containing lactic acid bacteria a day

Interventions/Control_2

Take two placebo capsules a day

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Adult male and female from 20 to 60 years old
(2) Subjects who can take capsules

Key exclusion criteria

(1) Subjects with symptoms of hay fever except cedar pollinosis at the stage of screening conducted from November 2017 to January 2018
(2) Subjects who regularly drink or eat live fungus-containing foods including lactic acid bacteria beverage, food,and preparation, and Bacillus natto
(3) Subjects smorking
(4) Pregnant women, lactating women, or women who want to get pregnant during the trial period
(5)Subjects who show hypersensitivity symptoms to lactic acid bacteria foods
(6) Subjects who investigator judge not suitable to participate in the trial

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Gen Sugita

Organization

Wakayama Medical University School of Medicine

Division name

Department of Otolaryngology

Zip code


Address

811-1 Kimiidera, Wakayama 641-8509, Japan

TEL

073-447-2300

Email

genent@wakayama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yuta Yamamoto

Organization

Wakayama Medical University School of Medicine

Division name

Department of Anatomy and Cell Biology

Zip code


Address

811-1 Kimiidera, Wakayama 641-8509, Japan

TEL

073-441-0616

Homepage URL


Email

yuta-y@wakayama-med.ac.jp


Sponsor or person

Institute

Department of Otolaryngology, Wakayama Medical University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Nitto Pharmaceutical Industries, LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 11 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 11 Month 02 Day

Date of IRB

2017 Year 11 Month 14 Day

Anticipated trial start date

2017 Year 11 Month 20 Day

Last follow-up date

2018 Year 05 Month 31 Day

Date of closure to data entry

2018 Year 10 Month 07 Day

Date trial data considered complete

2018 Year 10 Month 08 Day

Date analysis concluded

2020 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 11 Month 14 Day

Last modified on

2020 Year 02 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033917


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name